GMED
Globus Medical, Inc.
Platform & Compounding FCF
B-
65.0 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
5.5%
-
Operating Margin Trend
-1.89 pp/yr
-
5yr Avg ROE
4.8%
-
5yr Share-Count CAGR
7.3%
-
5yr Revenue CAGR
32.3%
-
5yr EPS CAGR
28.4%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
16.0%
-
5yr FCF/NI Conversion
1.68x
-
Net Debt / EBITDA
-0.60x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
11.41
Stability
Weight: 5%
B-
62
-
EPS Volatility (σ/μ)
0.58
-
Piotroski F-Score
8
-
Negative-Revenue Years (5)
0/5
3 of 3 gurus held; 2 added; 1 trimmed.
- Holders
- 3
- Avg Δ position
-
+2.0%
- New buys
- 0
- Full exits
- 0